ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARCT Arcturus Therapeutics Holdings Inc

26.32
-1.32 (-4.78%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 607,514
Bid Price 26.30
Ask Price 29.40
News -
Day High 27.46

Low
17.52

52 Week Range

High
43.81

Day Low 26.26
Company Name Stock Ticker Symbol Market Type
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.32 -4.78% 26.32 18:38:02
Open Price Low Price High Price Close Price Prev Close
27.46 26.26 27.46 26.32 27.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,455 607,514 $ 26.87 $ 16,326,352 - 17.52 - 43.81
Last Trade Time Type Quantity Stock Price Currency
16:20:00 formt 304 $ 26.32 USD

Arcturus Therapeutics (ARCT) Options Flow Summary

Overall Flow

Bearish

Net Premium

-451k

Calls / Puts

50.00%

Buys / Sells

0.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

Arcturus Therapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
708.68M 26.92M - 166.8M -29.73M -1.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arcturus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARCT Message Board. Create One! See More Posts on ARCT Message Board See More Message Board Posts

Historical ARCT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week32.3233.1126.2629.89513,685-6.00-18.56%
1 Month33.4235.67526.2631.90528,944-7.10-21.24%
3 Months32.6943.8126.2635.25485,194-6.37-19.49%
6 Months22.0443.8117.5230.43449,1754.2819.42%
1 Year27.8043.8117.5229.74432,403-1.48-5.32%
3 Years40.3864.973511.7029.21538,615-14.06-34.82%
5 Years7.50129.715.7039.15556,00018.82250.93%

Arcturus Therapeutics Description

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

Your Recent History

Delayed Upgrade Clock